CCL5 and chronic obstructive pulmonary disease: The investigators also reported higher levels of sputum CCL5 in COPD from tobacco smoking than disease secondary to wood burning, implicating a potential role for this biomarker to delineate between these two disease drivers, though more investigations are warranted.